Raymund Razonable to Antiviral Agents
This is a "connection" page, showing publications Raymund Razonable has written about Antiviral Agents.
Connection Strength
0.461
-
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model. Mayo Clin Proc. 2021 05; 96(5):1250-1261.
Score: 0.086
-
Role of letermovir for prevention of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation. Curr Opin Infect Dis. 2018 08; 31(4):286-291.
Score: 0.072
-
Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation. Expert Rev Clin Pharmacol. 2018 Aug; 11(8):773-788.
Score: 0.072
-
New Developments in the Management of Cytomegalovirus Infection After Transplantation. Drugs. 2018 Jul; 78(11):1085-1103.
Score: 0.071
-
Cytomegaloviraemia clearance with foscarnet during renal replacement therapy. J Antimicrob Chemother. 2018 02 01; 73(2):548-549.
Score: 0.069
-
Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof). Mayo Clin Proc. 2020 07; 95(7):1454-1466.
Score: 0.020
-
Application of a New Paradigm for Cytomegalovirus Disease Prevention in Mayo Clinic's First Face Transplant. Mayo Clin Proc. 2019 01; 94(1):166-170.
Score: 0.019
-
Drug-resistant cytomegalovirus: clinical implications of specific mutations. Curr Opin Organ Transplant. 2018 08; 23(4):388-394.
Score: 0.018
-
HHV-6 in liver transplantation: A literature review. Liver Int. 2018 02; 38(2):210-223.
Score: 0.017
-
A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2013 Oct; 15(5):487-92.
Score: 0.013
-
Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. Transpl Infect Dis. 2016 Apr; 18(2):210-5.
Score: 0.004